About FDA

Academic MOUs

MOU No.PurposePartiesFDA Lead Center or
Office/ Contact
Effective DateExpiration
Date
224-11-0024Establishes a collaborative framework between the FDA and the University of Florida through a variety of programs, including collaborative education and research. Term Extension Modification.University of FloridaCDER
Ryan Chatman
(301) 796-2106
09-21-201109-19-2021
225-02-8001Establishes terms of collaboration between FDA and UMD to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.University of MDOC
Eileen Parish
(301) 796-8522
09-04-2002Indefinite
225-03-6000Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.University of HoustonCDRH
Michelle Chenault
(240) 276-3815
03-29-2003Indefinite
225-03-8002Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.VA Polytechnic InstituteOC
Eileen Parish
(301) 796-8522
03-13-2003Indefinite
225-03-8003Establishes terms of collaboration between FDA and Howard University to support shared interest in scientific progress affecting human and animal health and medicine through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.Howard UniversityOC
Eileen Parish
(301) 796-8522
05-29-2003Indefinite
225-04-4003Establishes a framework for collaborative research and development and emergency triage response efforts on the subject of Homeland Security.University of CA, Lawrence Livermore National LaboratoryORA
Jeanne Roman
(301) 827-0947
04-14-2004Indefinite
225-05-6000To establish terms of collaboration between FDA and BWH to support shared interests and to begin the initiative "The FDA Brigham Elective Program for Residents in the Department of Medicine."Brigham and Women's HospitalCDRH
Anindita Saha
(301) 796-2537
Mimi Nguyen
(301) 796-4125
05-09-2006 
225-05-6001Establishes collaboration between FDA, Duke University, and Duke University Health System, Inc. in sharing scientific information.Duke University

Duke University Health System, Inc.
CDRH
Annindita Saha
(301) 796-2537
Mimi Nguyen
301-796-4125
09-18-2006Indefinite
225-07-6001Establishes the terms for collaborative research between the FDA and Stanford University to promote scientific progress in animal and human medicine. Amended to change POC and termination date.Stanford UniversityCDRH
Anindita Saha
(301-796-2537
Mimi Nguyen
301-796-4125
05-11-2016Indefinite
225-07-8005To establish terms of collaboration between FDA and Duke, as a part of FDA's Critical Path Initiative. This MOU will serve as the basis of a Public Private Partnership hosted by Duke to systematically modernize the clinical trial process.Duke UniversityOC
Melissa Robb
(301) 827-1516
09-22-2007Indefinite
225-07-8008 -1
replaces
227-07-8008 and
225-02-8000
To establish collaboration in the areas of advanced scientific training, information exchange and stimulation of cooperative research activities in biotechnology, bioethics, and nanotechnology, particularly with the Institute of NanoBioTechnology.John Hopkins UniversityOC
Eileen Parish
(301) 796-8522
05-20-201505-20-2020
225-07-8405Forms the basis for development of scientific collaborations, outreach and educational
initiatives and intellectual partnerships between FDA and USM.
University System of MarylandOffice of the Chief ScientistApril 2, 2018Indefinite
225-11-0012Forms the basis for the initial relations between FDA and the University of Hawaii for sabbaticals, research and scientific education.University of Hawaii at Manoa, Office of Public Health StudiesOMH
Richardae Araojo
(301) 796-8000
04-24-2012Indefinite
225-12-0004Establishes the collaboration between The United States Food and Drug Administration (FDA) and Thomas Jefferson University to share interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Program. Time Extension AmendmentThe Thomas Jefferson UniversityCDER
Ryan Chatman
(301) 796-2106
12-09-201112-09-2021
225-12-0011Forms the basis for the initial relations between FDA and the University of Hawaii, College of Pharmacy for sabbaticals, research and scientific educationUniversity of Hawaii Hilo, College of PharmacyOMH
Richardae Araojo
(301) 796-8000
03-30-2012Indefinite
225-12-0018Establishes the terms between the Food and Drug Administration (FDA) and Stanford University (Stanford) to promote scientific progress through exchange of scientific capital in diverse fields of science that affect human and animal health and medicine.Stanford UniversityGerald J. Dal Pan, MD MHS(301) 796-238005-17-2012Indefinite
225-12-0029Forms the basis for the initial relations between FDA and Meharry Medical College (Meharry) for sabbaticals, research and scientific education.Meharry Medical CollegeOMH
Richardae Araojo
(301) 796-8000
06-21-2012Indefinite
225-12-0041Collaborate to develop strategic plans, set priorities, and leverage resources and expertise from multiple sources, including the private sector, toward the goals of identifying scientific gaps in the design, implementation and interpretation of clinical trials to improve analgesic, anesthetic, and addiction treatments for the benefit of the public health.University of RochesterCDER
Bob A. Rappaport, MD
04-29-201304-28-2018
225-93-2001IL Inst. Tech., participation in short courses, workshops, & training programs in food safety and technology.IL Inst. TechCFSAN
Don Zink
(240) 402-1693
09-03-1993Indefinite
225-13-0020Establishes terms of collaboration between FDA and the University of Hamburg for development of scientific collaborations, outreach and educational initiatives, and intellectual partnerships.University of HamburgCFSAN
Eric Brown, PhD
(240) 402-2020
09-05-2013Indefinite
UMBCEstablishes terms of colla boration between FDA and UMBC to support collaboration on specific projects related to biotechnology process validation, but can serve as a basis for future collaboration in other areas.University of MD Baltimore CountyCDER
Dr. Kurt Brorson
(301) 796-2193
07-25-2003Indefinite
225-14-0005Establishes terms of collaboration between FDA and the President and Fellows of Harvard College on behalf of Harvard Medical School pursued through a variety of programs including collaborative research, public outreach, extension activities, cooperative international initiatives, and disciplinary training.President and Fellows of Harvard College on behalf of Harvard Medical SchoolCDRH
Danica Marinac-Dabic, MD, PhD
(301) 796-6689
04-08-201404-07-2019
225-14-0007(OC)This Memorandum of Understanding (MOU) states the mutual intention of the parties to seek opportunities for collaboration and to promote shared interests in various science-based academic initiatives, fellowships, and student internships.York College of the City University of New YorkOMH
Richardae Araojo
(301) 796-8000
02-20-2014Indefinite
225-14-014Promoting scientific progress through exchange of scientific capital in the areas of public health and regulatory research.Regents of the University of MinnesotaCDER
Mark Lauda
(301) 796-0381
09-04-201409-03-2019
225-14-8001Establishes terms of collaboration between FDA and the University of Cologne to share interests in promoting scientific progress through knowledge exchange of scientific capital in pharmacology and translational research with regard to characterization of drug transporters.University of CologneCDER
Nisha Bruce
(301) 796-2600
06-30-2014Indefinite
225-15-002Collaboration to promote these shared interests, which can be pursued through information sharing in regulatory science research, training, sabbaticals, postdoctoral fellowships, and student internships.University of Massachusetts AmherstORA/WEAC
Brian L. Baker
(871) 856-9701
09-12-201409-11-2019

225-15-006

Collaboration to promote these shared interests, which can be pursued through information sharing in regulatory science research, training, sabbaticals, postdoctoral fellowships, and student internships.Morehouse School of MedicineOMH
Richardae Araojo
(301) 796-8000
12-22-2014Indefinite
225-15-013
Amendment #1
Shared interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Programs. This modification is to extend the termination date to June 30, 2021.University of California at San DiegoCDER  05-08-201806-30-2021
225-16-001
Identify indicators of cardiovascular risk, predict adverse cardiovascular events associated with therapeutic interventions, and improve the clinical utility of biomarker technologies as diagnostic and assessment tools that facilitate developing safer and more effective cardiovascular therapies, diagnostic and assessment tools.
Duke University Cardiac Safety Research ConsortiumNorman Stockbridge, MD, PhD
(301) 796-9841
10-28-2015Indefinite
225-16-005
Establish opportunities for scientific and medical exchange between the FDA scientific staff and the University’s science students and academicians through collaborative research and training.
University of RochesterOCS
Eileen Parish, M.D.
(301) 796-8522 
12-14-20152-13-2020
225-16-014Promote scientific capital, training, research, training, and research expertise. Information sharing in regulatory science research, training, sabbaticals, postdoctoral, recruitment opportunities, fellowships, and student internships.Rutgers UniversityORA
Paula Davy
(718) 340-7942
Nazmul Hassan
(718) 62-5707
01-26-201601-25-2021
225-16-021Establishes terms for collaboration through a variety of programs, e.g., research, graduate student training, and exchange of scientists, exchange of staff, sabbaticals, post-doctoral fellowships, and student interns.Worcester Polytechnic InstituteGerald J. Dal Pan, MD, MHS, CDER
301-796-2380
08-25-2016Indefinite
225-16-023Promote share interests in collaborative education and research.Virginia Commonwealth UniversityPadmaja Mummaneni, Ph.D.
301-796-2027
08-16-201608-15-2021
225-17-002
Replaced MOU 225-11-0006
Shared interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Programs.University of California San FranciscoCDER
Padmaja Mummaneni,
301-796-2027
 10-9-2016 10-8-2021
225-17-026Promote scientific progress through exchange of scientific capital
to enhance the assessment of safety and efficacy of FDA-regulated products through joint educational and training fellowship programs.
Duke UniversityCDER
Padmaja Mummaneni, PhD
301-796-2027 
 
08-03-201708-02-2022
225-18-013Establishes a framework for this collaboration to enhance mutual cybersecurity and technology related interactions in education and research.Montgomery CollegeOffice of the Chief Information Officer
Craig Taylor
Craig.Taylor@fda.hhs.gov
301-796-8696
03-28-2018Indefinite
225-18-015Promote shared interests in various science-based academic initiatives, fellowships, internships, sabbaticals, research and scientific education.Yale UniversityOffice of Minority Health
CAPT Richardae Araojo
301-796-1152 
03-28-2018Indefinite
225-18-016Shared interests in promoting scientific progress through exchange of scientific capital in public health, epidemiology and research.State University of New York at BuffaloOffice of Minority Health/OC
Yeruk (Lily) Mulugeta
301-796-3162
05-14-201805-13-2023
225-18-029Collaborate on biomedical engineering projects of importance to the regulatory science priorities at CDRH. The parties have an interest in better understanding the bioengineering performance of many regulated medical and surgical devices.University of KentuckyEdward Margerrison, Ph.D.
(301) 796-0262
09-18-201809-18-2023
225-18-21Promotes scientific progress through exchange of scientific capital in clinical pharmacy and pharmacology training, research programs, clinical research in pharmacotherapy, biopharmaceutics, clinical pharmacology and translational science.U.S. Food and Drug Administration and University of GeorgiaCDER08-28-201808-27-2023
225-19-003The purpose of this MOU is to facilitate scientific progress through collaborative, interdisciplinary research, educational and training initiatives between the FDA and MIT Media Lab.Massachusetts Institute of TechnologySean Khozin, MD, MPHJanuary 30, 2019January 30, 2024

 

 
 

Page Last Updated: 02/12/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English